T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$1.36B |
| 2 |
Philip Morris
PM
|
+$1.3B |
| 3 |
Amazon
AMZN
|
+$1.21B |
| 4 |
Stryker
SYK
|
+$1.12B |
| 5 |
AET
Aetna Inc
AET
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$1.46B |
| 2 |
Gilead Sciences
GILD
|
+$1.1B |
| 3 |
Walt Disney
DIS
|
+$866M |
| 4 |
Akamai
AKAM
|
+$703M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.69% |
| 2 | Consumer Discretionary | 15.01% |
| 3 | Financials | 13.64% |
| 4 | Technology | 12.55% |
| 5 | Industrials | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Cousins Properties
CUZ
$4.93B
| $576K | ﹤0.01% |
19,661
| – | – |
|
1902
Scansource
SCSC
$1.06B
| $576K | ﹤0.01% |
14,270
-2,600
| -15% | -$90.7K |
|
|
UCB
1903
United Community Banks
UCB
$4.43B
| $575K | ﹤0.01% |
31,109
+7,600
| +32% | +$135K |
|
|
OKSB
1904
DELISTED
Southwest Bancorp Inc/OK
OKSB
| $573K | ﹤0.01% |
38,100
| – | – |
|
|
TIVO
1905
DELISTED
TIVO INC
TIVO
| $573K | ﹤0.01% |
60,200
+9,600
| +19% | +$77.2K |
|
1906
First Financial Bancorp
FFBC
$3.6B
| $570K | ﹤0.01% |
31,342
| – | – |
|
1907
First Financial Bankshares
FFIN
$5.04B
| $570K | ﹤0.01% |
38,516
+6,400
| +20% | +$87.9K |
|
|
PMC
1908
DELISTED
PharMerica Corporation
PMC
| $570K | ﹤0.01% |
25,771
+5,080
| +25% | +$135K |
|
|
NAVG
1909
DELISTED
Navigators Group Inc
NAVG
| $569K | ﹤0.01% |
13,560
| – | – |
|
|
PETX
1910
DELISTED
Aratana Therapeutics, Inc.
PETX
| $566K | ﹤0.01% |
102,601
| – | – |
|
|
ESV
1911
DELISTED
Ensco Rowan plc
ESV
| $565K | ﹤0.01% |
13,625
-101,738
| -88% | -$4.15M |
|
1912
Strategy Inc
MSTR
$38.2B
| $564K | ﹤0.01% |
31,360
+100
| +0.3% | +$1.62K |
|
1913
Plexus
PLXS
$7.04B
| $563K | ﹤0.01% |
14,250
+2,400
| +20% | +$85K |
|
|
MDR
1914
DELISTED
McDermott International
MDR
| $560K | ﹤0.01% |
45,650
+10,733
| +31% | +$102K |
|
1915
iShares MSCI United Kingdom ETF
EWU
$4.13B
| $558K | ﹤0.01% |
17,800
+8,650
| +95% | +$262K |
|
1916
Northwest Natural Holdings
NWN
$2.14B
| $558K | ﹤0.01% |
10,370
+10
| +0.1% | +$515 |
|
1917
Otter Tail
OTTR
$3.9B
| $558K | ﹤0.01% |
18,850
| – | – |
|
1918
VEON
VEON
$3.93B
| $555K | ﹤0.01% |
5,212
+195
| +4% | +$17.2K |
|
1919
Westlake Corp
WLK
$10.2B
| $555K | ﹤0.01% |
11,980
+2,160
| +22% | +$98K |
|
|
BGG
1920
DELISTED
Briggs & Stratton Corp.
BGG
| $555K | ﹤0.01% |
23,200
-4,900
| -17% | -$101K |
|
|
GPT
1921
DELISTED
Gramercy Property Trust
GPT
| $554K | ﹤0.01% |
21,859
+3,333
| +18% | +$74.8K |
|
1922
Larimar Therapeutics
LRMR
$444M
| $550K | ﹤0.01% |
6,867
-1,997
| -23% | -$158K |
|
|
TUBE
1923
DELISTED
TubeMogul, Inc.
TUBE
| $550K | ﹤0.01% |
+42,532
| New | +$509K |
|
1924
Hallador Energy
HNRG
$730M
| $549K | ﹤0.01% |
120,179
-10,354
| -8% | -$49.9K |
|
1925
Lithia Motors
LAD
$8.32B
| $547K | ﹤0.01% |
6,260
| – | – |
|
Similar funds
T. Rowe Price Associates's Q1 2016 Portfolio in Review
As of Q1 2016, T. Rowe Price Associates held 2,594 positions worth $468B, down 1.5% from $475B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q1 2016 filing shows 78 new, 1,210 increased, 770 reduced and 91 closed positions. Its largest new stake was BRF SA: 5,750,603 shares worth $81.8M. The largest sale was Bausch Health, an estimated $1.46B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2016 buy was BRF SA: 5,750,603 shares worth $81.8M.
- T. Rowe Price Associates added most to NXP Semiconductors in Q1 2016, an estimated $1.36B increase.
- T. Rowe Price Associates's biggest Q1 2016 reduction was Bausch Health, cutting an estimated $1.46B.
- T. Rowe Price Associates fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $496M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $468B portfolio in Q1 2016.
- T. Rowe Price Associates opened 78 new positions and closed 91 in Q1 2016.
- T. Rowe Price Associates's portfolio value fell 1.5% quarter-over-quarter to $468B.
Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.